Dopaminergic mechanisms in cranial dystonia.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D008538:Meige Syndrome / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D010300:Parkinson Disease / Q000503:physiopathology
D014150:Antipsychotic Agents; D004298:Dopamine